Key points from article :
Ichor Therapeutics is a biotechnology company focused on developing drugs for age-related diseases.
LYSOCLEAR for age-related macular degeneration and Stargardt’s macular degeneration going into Phase I clinical trials.
Age-related macular degeneration (AMD) is the leading cause of vision loss among people over the age of 50.
With time, different by-products are formed that accumulate in the lysosomes of RPE cells.
LYSOCLEAR is an enzyme product that can enter the lysosomes of RPE cells and destroy toxic A2E accumulations.
We are now seeing the first SENS therapies proposed back in 2000s moving into clinical trials.
